Discontinued — last reported Q4 '25
Over 3 years (FY 2021 to FY 2025), HST — Restructuring costs shows an upward trend with a 91.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High costs indicate active operational transformation, which should ideally lead to improved future profitability.
Expenses incurred by the Health and Science Technologies segment to reorganize operations, including severance, facility...
Commonly reported by industrial companies undergoing cost-reduction or integration programs.
iex_segment_hst_restructuring_costs| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $500.00K | $600.00K | $0.00 | $100.00K | $100.00K | $400.00K | $600.00K | $300.00K | $2.70M | $1.50M | $1.90M | $500.00K | $11.40M | $100.00K | $0.00 | $400.00K |
| QoQ Change | — | +20.0% | -100.0% | — | +0.0% | +300.0% | +50.0% | -50.0% | +800.0% | -44.4% | +26.7% | -73.7% | >999% | -99.1% | -100.0% | — |
| YoY Change | — | — | — | — | -80.0% | -33.3% | — | +200.0% | >999% | +275.0% | +216.7% | +66.7% | >999% | — | — | — |